Even though the identification of conolidine as a potential novel analgesic agent gives yet another avenue to address the opioid disaster and deal with CNCP, even further scientific tests are required to understand its mechanism of motion and utility and efficacy in handling CNCP.By binding to ACKR3, conolidine is believed to inhibit this scavengin